Search results :

Didanosine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J05AF02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13
Diarrhoea 15% - 28% x x x x x x x x x x x x x
Neurological symptom 12% - 20% x x x x x x x x x x x x
Neuropathy 12% - 20% x x x x x x x x x x x x x
Abdominal pain postmarketing, 7% - 13% x x x x x x x x x x x x x
Rash 5% - 9% x x x x x x x x x x x x x
Pruritus 5% - 9% x x x x x
Pancreatitis postmarketing, 2% - 7% x x x x x x x x
Lactic acidosis postmarketing x x x x x x x x x x x x x
Alopecia postmarketing x x x x x x x x x x x x x
Anaemia postmarketing x x x x x x x x x x x x x
Anorexia postmarketing x x x x x x x x x x x x x
Arthralgia postmarketing x x x x x x x x x x x x x
Asthenia postmarketing x x x x x x x x x x x x x
Diabetes mellitus postmarketing x x x x x x x x x x x x
Dyspepsia postmarketing x x x x x x x x x x x x x
Body temperature increased postmarketing x x x x x x x x x x x x x
Flatulence postmarketing x x x x x x x x x x x x x
Hepatitis postmarketing x x x x x x x x x x x x x
Hyperglycaemia postmarketing x x x x x x x x x x x x x
Portal hypertension postmarketing x x x x
Hypoglycaemia postmarketing x x x x x x x x x x x x x
Renal failure acute postmarketing x x x x x x x x x x x x x
Leukopenia postmarketing x x x x x x x x x x x x x
Metabolic disorder postmarketing x x x x x x x x x x x x x
Myopathy postmarketing x x x x x x x x x x x x x
Musculoskeletal disorder postmarketing x x x x x x x x x x x x x
Optic neuritis postmarketing x x x x x x x x x x x x x
Pain postmarketing x x x x x x x x x x x x x
Neuropathy peripheral postmarketing x x x x x x x x x x x x x
Retinal disorder postmarketing x x x x x x x
Rhabdomyolysis postmarketing x x x x x x x x x x x x x
Sialoadenitis postmarketing x x x x x x x x x x x x x
Thrombocytopenia postmarketing x x x x x x x x x x x x x
Dry mouth postmarketing x x x x x x x x x x x x x
Chills postmarketing x x x x x x x x x x x x x
Hepatic failure postmarketing x x x x x x x x x x x x x
Retinal depigmentation postmarketing x x x x x x
Leukoderma postmarketing x x x x x x x
Myalgia postmarketing x x x x x x x x x x x x x
Hepatotoxicity postmarketing x x x x x x x x x x x
Hepatobiliary disease postmarketing x x x x x
Dry eye postmarketing x x x x x x x x x x x x x
Anaphylactoid reaction postmarketing x x x x x x x x x x x x x
Parotid gland enlargement postmarketing x x x x x x x x x x x x x
Serum amylase increased postmarketing x x x x x x x x x
Alkaline phosphatase serum increased postmarketing x x x x x x x x x
Blood and lymphatic system disorders postmarketing x x x x x
Symptomatic hyperlactatemia postmarketing x x x x x x x
Hepatic steatosis postmarketing x x x x x x x x x x x x x
Acquired immunodeficiency syndrome x
Agranulocytosis x
Breast feeding x
Infection x
Headache x x x x x x x x x x x x x
Blood disorder x x x x x x x x
Hepatomegaly x x x x x x x x x x x x x
Hypersensitivity x
Inflammation x
Nephropathy x
Nausea x x x x x x x x x x x x x
Neuritis x
Numbness x
Vomiting x x x x x x x x x x x x x
Hepatic function abnormal x
Hepatocellular injury x
Sickness x
Stomach ache x
Function kidney decreased x
Discomfort x
Buffalo hump x
Drug interaction x
Hyperuricaemia x
Fat redistribution x x x x x x x
Tingling sensation x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Didanosine / ] < 50 c/mL

Side effects:50
Source:medicines.org.au

DIDANOSINE

Side effects:46
Source:FDA Structured Product Label

didanosine / Videx EC

Side effects:47
Source:FDA

didanosine / Videx EC

Side effects:48
Source:FDA

DIDANOSINE / VIDEX

Side effects:48
Source:FDA

didanosine / VIDEX

Side effects:47
Source:FDA

didanosine / VIDEX

Side effects:48
Source:FDA

DIDANOSINE

Side effects:50
Source:FDA Structured Product Label

didanosine

Side effects:50
Source:FDA Structured Product Label

DIDANOSINE / VIDEX EC

Side effects:49
Source:FDA

DIDANOSINE

Side effects:50
Source:FDA Structured Product Label

DIDANOSINE

Side effects:51
Source:FDA Structured Product Label

DIDANOSINE / VIDEX EC

Side effects:64
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label